Phil Bendele
About Phil Bendele
Phil Bendele is a Senior Vice President at Inotiv, with a strong background in biotechnology and pharmaceuticals. He has held various leadership roles, including COO/CFO and CEO at Bolder BioPATH, Inc., and has extensive experience in drug discovery and life sciences.
Current Role at Inotiv
Phil Bendele has served as Senior Vice President at Inotiv since 2021. In this role, he leverages his extensive experience in the pharmaceutical sector to oversee operations and strategic initiatives. His background in biotechnology and drug discovery enhances his capability to manage complex projects effectively. Bendele's leadership at Inotiv is characterized by a focus on innovation and operational excellence within the life sciences industry.
Previous Experience at Bolder BioPATH, Inc.
Phil Bendele held multiple roles at Bolder BioPATH, Inc., serving as COO/CFO from 2001 to 2019 and later as CEO from 2019 to 2021. During his 18 years as COO/CFO, he was instrumental in the company's operational and financial management. His transition to CEO allowed him to further influence the company's strategic direction. Bendele's tenure at Bolder BioPATH was marked by significant contributions to drug discovery and life sciences.
Career Background in Recruitment and Business Development
Before his roles in the pharmaceutical industry, Phil Bendele worked at Manpower International as a Recruiter and Business Development Manager from 1996 to 2000. This experience provided him with foundational skills in recruitment and business strategy, which he later applied in the life sciences sector. He also served as Regional Director at Certified Communications for a brief period in 2000-2001.
Education and Academic Qualifications
Phil Bendele's academic background includes a Master of Business Administration (MBA) from Colorado State University, where he studied from 2004 to 2006. He also holds a Bachelor of Arts in Business and International Studies from Abilene Christian University, completed from 1994 to 1997. Earlier, he studied Business Administration and Management at Texas Christian University from 1991 to 1993. His educational qualifications support his expertise in managing complex projects in the pharmaceutical industry.
Expertise in Biotechnology and Pharmaceuticals
Phil Bendele possesses strong skills in biotechnology, which enhance his ability to manage complex projects within the pharmaceutical sector. His extensive expertise in drug discovery and life sciences contributes to his leadership roles in the industry. Bendele's proven track record of financial acumen supports his strategic decision-making, making him a key figure in the pharmaceutical landscape.